[Issue Brief] HIV & opportunistic infection treatment: Spotlight on access gaps

This issue brief provides information regarding the changing product landscape, and updates on pricing and access to three critical medical interventions: optimal HIV therapy with dolutegravir; paediatric HIV therapy; and opportunities to improve treatment for two common opportunistic infections: cryptococcal meningitis and Kaposi’s sarcoma.
Page updated: 17 July 2017
↑ To top